Loading…
SOPHiA GENETICS SA is projected to rise to $7.10 by 2027, a +25% move from its current price of $5.67. SOPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.52 | $5.67 | $5.83 | +0.04% |
| Aug 4 | $5.46 | $5.67 | $5.90 | +0.08% |
| Aug 5 | $5.41 | $5.68 | $5.95 | +0.13% |
| Aug 6 | $5.38 | $5.68 | $6.00 | +0.17% |
| Aug 7 | $5.35 | $5.68 | $6.04 | +0.21% |
| Aug 8 | $5.32 | $5.68 | $6.08 | +0.25% |
| Aug 9 | $5.29 | $5.69 | $6.11 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.29 | $5.69 | $6.11 | +0.30% |
| Week 2 | $5.15 | $5.70 | $6.32 | +0.59% |
| Week 3 | $5.05 | $5.72 | $6.48 | +0.89% |
| Week 4 | $4.97 | $5.74 | $6.63 | +1.19% |
| Week 5 | $4.90 | $5.75 | $6.76 | +1.48% |
| Week 6 | $4.84 | $5.77 | $6.89 | +1.78% |
| Week 7 | $4.78 | $5.79 | $7.01 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SOPHiA GENETICS SA is a cloud-native software technology company operating in the healthcare space. It offers the SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its platform and related solutions are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
SOPHiA GENETICS SA is currently priced at $5.72 and traded under the SOPH symbol. The asset has a market cap of $479.88M and holds the 2892 rank by market capitalization.
The forecast implies a bullish long-run price trajectory, with the 2026 average at $5.72 and a progression to higher targets in subsequent years. The 2026 min is $4.10 and the max is $8.10 with an ROI of 0 and Neutral sentiment. By 2027 the avg target is $7.72 (ROI 34.9, Bullish), rising to $10.03 by 2028 (ROI 75.4, Bullish) and $12.31 by 2029 (ROI 115.2, Bullish).
By 2030 the avg target is $13.06 (ROI 128.3, Bullish) and the long-run path extends toward $85.95 by 2050 (ROI 1402.5, Bullish).
A major floor 20.5% below — a decisive break under it would weaken the trend.
The nearest floor, 7.8% below — buyers have tended to step in here.
The nearest ceiling, 14.6% above — a clean break opens room to run.
A major ceiling 24.7% above — clearing it would confirm fresh momentum.
Key SOPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SOPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.64 | Buy | $5.71 | Sell |
| MA 10 | $5.92 | Sell | $5.77 | Sell |
| MA 20 | $5.79 | Sell | $5.75 | Sell |
| MA 50 | $5.45 | Buy | $5.52 | Buy |
| MA 100 | $5.18 | Buy | $5.27 | Buy |
| MA 200 | $4.95 | Buy | $4.91 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.35 | Neutral |
| Stoch RSI (14) | 11.75 | Buy |
| CCI (20) | -35.85 | Neutral |
| Williams %R (14) | -87.37 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -1.73 | Sell |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 12.63 | Buy |
| TRIX (15) | 0.38 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 32.07 | Neutral |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 5.53 | Buy |
| ADX (14) | 13.57 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is bullish overall. RSI14 sits at 60, and the price action is above the SMA50 of $5.33 and above the SMA200 of $4.90.
The near-term range spans from a low of $4.73 to a high of $6.92 over the last 30 days. The immediate support level is $4.88, with resistance at $6.50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.10 | $5.67 | $7.72 | 0% | Neutral | |
| $5.66 | $7.10 | $9.42 | +25% | Bullish | |
| $6.88 | $8.87 | $12.21 | +56% | Bullish | |
| $8.04 | $10.62 | $15.05 | +87% | Bullish | |
| $8.30 | $11.18 | $16.24 | +97% | Bullish | |
| $8.97 | $12.32 | $18.27 | +117% | Bullish | |
| $9.32 | $13.02 | $19.70 | +130% | Bullish | |
| $9.53 | $13.54 | $20.83 | +139% | Bullish | |
| $11.51 | $16.60 | $25.96 | +193% | Bullish | |
| $13.58 | $19.87 | $31.54 | +250% | Bullish | |
| $16.69 | $26.13 | $44.12 | +361% | Bullish | |
| $33.35 | $58.60 | $108.26 | +933% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.10 | $5.67 | $6.95 | +0.00% |
| September 2026 | $5.04 | $5.96 | $7.25 | +5.13% |
| October 2026 | $4.95 | $5.89 | $7.25 | -1.15% |
| November 2026 | $4.92 | $5.89 | $7.30 | -0.05% |
| December 2026 | $5.13 | $6.18 | $7.72 | +4.92% |
Click any year to see its month-by-month SOPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SOPH price prediction for 2026 points to an average of $5.67 (low $4.10, high $7.72) — a potential gain of 0% on today's $5.67. A consolidation phase looks the most probable path here.
In 2027, SOPH is projected to trade between $5.66 and $9.42, averaging $7.10 — a potential gain of +25% from today's $5.67. That is up +25% on the projected 2026 average. Momentum favours further upside here.
SOPHiA GENETICS SA's 2028 outlook centres on $8.87, within a $6.88 to $12.21 range. That is up +25% on the projected 2027 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, SOPH could reach as high as $15.05, with a base case around $10.62 and support toward $8.04 — roughly +87% from $5.67. Momentum favours further upside here.
Expect SOPH to range from $8.30 to $16.24 through 2030. The $11.18 average target implies a +97% move from current prices. That is up +5% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The SOPH price prediction for 2031 points to an average of $12.32 (low $8.97, high $18.27) — a potential gain of +117% on today's $5.67. Momentum favours further upside here.
In 2032, SOPH is projected to trade between $9.32 and $19.70, averaging $13.02 — a potential gain of +130% from today's $5.67. That is up +6% on the projected 2031 average. Buyers look set to stay in control over this stretch.
SOPHiA GENETICS SA's 2033 outlook centres on $13.54, within a $9.53 to $20.83 range. That is up +4% on the projected 2032 average. That marks a +139% change versus current levels. Momentum favours further upside here.
By 2034, SOPH could reach as high as $25.96, with a base case around $16.60 and support toward $11.51 — roughly +193% from $5.67. Buyers look set to stay in control over this stretch.
Expect SOPH to range from $13.58 to $31.54 through 2035. The $19.87 average target implies a +250% move from current prices. That is up +20% on the projected 2034 average. Momentum favours further upside here.
The SOPH price prediction for 2040 points to an average of $26.13 (low $16.69, high $44.12) — a potential gain of +361% on today's $5.67. Buyers look set to stay in control over this stretch.
In 2050, SOPH is projected to trade between $33.35 and $108.26, averaging $58.60 — a potential gain of +933% from today's $5.67. That is up +124% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SOPH today (≈ 176.366843 SOPH) could be worth
$10,334.4
+$9,334.4 (+933%) by 2050 · US Dollar
Based on the average projected SOPH price of $58.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SOPHwould be worth at today's price.
$1,000 invested in SOPH on Jul 31, 2025 (≈ 319.488806 SOPH) would be worth
$1,811.5
+$811.5 (+81.2%) today · 1.81× · US Dollar
Based on a SOPH entry price of $3.13 vs. today's $5.67.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.72 | $991.26 | -0.9% |
| 1 month ago | $5.59 | $1,014.31 | +1.4% |
| 3 months ago | $5.32 | $1,065.79 | +6.6% |
| 6 months ago | $5.35 | $1,059.81 | +6.0% |
| 1 year ago | $3.13 | $1,811.5 | +81.2% |
| All time (5.0y) ago | $18 | $315 | -68.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SOPH forecast.
Our base-case forecast reaches $11.00 around 2030.
Implied market cap at $11.00: $922.85M
The multi-year forecast shows a bullish trajectory with rising averages and ROI across years. In 2026 the average is $5.72 with a 0% ROI and Neutral sentiment. The path turns increasingly bullish from 2027 onward, with 2027 avg $7.72 (ROI 34.9, Bullish), 2028 avg $10.03 (ROI 75.4, Bullish), 2029 avg $12.31 (ROI 115.2, Bullish), and 2030 avg $13.06 (ROI 128.3, Bullish).
Further years continue the upwards trend: 2031 avg $14.81 (ROI 159, Bullish), 2032 avg $16.06 (ROI 180.8, Bullish), 2033 avg $16.92 (ROI 195.8, Bullish), 2034 avg $21.88 (ROI 282.5, Bullish), and 2035 avg $26.37 (ROI 361.1, Bullish).
The forecast extends to 2040 with an avg of $36.87 (ROI 544.5, Bullish) and to 2050 with an avg of $85.95 (ROI 1402.5, Bullish). These targets imply meaningful upside over the long term, though they are estimates and not guarantees. The path depends on conditions that support continued positive sentiment.
Tap a question to reveal the answer.
In 2030 the forecast average is $13.06, with a minimum of $9.60 and a maximum of $19.19, and an ROI of 128.3%. The sentiment for 2030 is Bullish.
The forecast shows a Neutral sentiment for 2026 and Bullish sentiment from 2027 onward, with rising average targets and positive ROI through 2050. These are estimates and not guarantees.
Yes. The forecast maximum for 2031 is $22.25, indicating potential upside above the 2030 level.
The current price is $5.72 and the market cap is $479.88M.
The 30-day range is $4.73 to $6.92, with current price $5.72. RSI14 is 60; SMA50 is $5.33 and SMA200 is $4.90. Support is $4.88 and resistance is $6.50.
SOPHiA GENETICS SA Community Discussion
0Share your SOPHiA GENETICS SA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.